STOCK TITAN

Crawford & Company (CRD-A) Financials

CRD-A NYSE
Trailing 12 months to September 30, 2026
Revenue $1.3B -3.6% YoY
Net Income $26.1M -19.9% YoY
Free Cash Flow $71.8M -15.8% YoY
Operating Cash Flow $79.1M -14.2% YoY
Market Cap $553.3M as of Nov 20, 2026
Price / Sales 0.4x on $1.3B revenue, trailing 12 months to September 30, 2026
Price / Earnings 21.2x on $26.1M net income, trailing 12 months to September 30, 2026
Price / Book 3.0x on $185.7M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 2, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRD-A SEC filings page.

Crawford & Company (CRD-A) reported $1.3B in revenue over the twelve months to Sep 30, 2026, down 3.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRD-A FY2025

FY2025 paired a mild revenue contraction with stable gross profit, sharply stronger cash generation, and lower debt.

Net income fell 26.2% to $19.6M, while operating cash flow rose 97.3%. With accounts receivable down 18.6% and operating cash flow equal to 518.7% of net income, FY2025’s cash result appears strongly aided by working-capital movement rather than profit alone, making cash conversion unusually important here.

Gross margin reached 28.0% as revenue fell 2.2%, showing margin resilience without volume growth. Capital expenditures were just 0.5% of revenue and 6.9% of operating cash flow, so cash generation does not depend on heavy reinvestment.

Long-term debt fell 24.8% while equity rose 10.1% in FY2025, indicating a less debt-heavy financing structure. Yet current liabilities rose 3.3% and the current ratio was 1.1384, so balance-sheet improvement is more visible in long-term leverage than in short-term liquidity.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 45 / 100
Financial Health Score 45/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Crawford & Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
50

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Crawford & Company scores 50/100 on it among other operating companies.

Growth
29

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Crawford & Company scores 29/100 on it among other operating companies.

Leverage
40

Crawford & Company carried $0.87 of long-term debt for every $1 of shareholders' equity at the end of fiscal year 2025, a debt-to-equity ratio of 0.87. With no EBITDA figure for fiscal year 2025, Crawford & Company is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 40/100 among other operating companies measured the same way.

Liquidity
27

Crawford & Company held $1.14 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.14. Liquidity ranks operating companies on that ratio, and Crawford & Company scores 27/100 among other operating companies.

Cash Flow
51

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Crawford & Company scores 51/100 on it among other operating companies.

Returns
70

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Crawford & Company scores 70/100 on it among other operating companies.

Piotroski F-Score Strong
7/9

Crawford & Company passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
5.19x

For every $1 of reported earnings, Crawford & Company generates $5.19 in operating cash flow ($101.8M OCF vs $19.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$329.9M
YoY-0.9%
QoQ0.0%
5Y CAGR+2.1%
10Y CAGR+1.1%

Crawford & Company generated $329.9M in revenue in Q3 2026. This represents a decrease of 0.9% from the same quarter a year earlier. It is unchanged from the prior quarter.

Net Income
$15.0M
YoY+21.0%
QoQ+11.6%
5Y CAGR+6.0%
10Y CAGR+3.2%

Crawford & Company reported $15.0M in net income in Q3 2026. This represents an increase of 21.0% from the same quarter a year earlier. Against the prior quarter it is up 11.6%.

EBITDA

Not reported for Q3 2026.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
$5.0M
YoY-83.0%
QoQ-73.1%

Crawford & Company generated $5.0M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 83.0% from the same quarter a year earlier. Against the prior quarter it is down 73.1%.

Cash & Debt
$79.0M
YoY+14.9%
QoQ+13.8%
5Y CAGR+16.4%
10Y CAGR+1.0%

Crawford & Company held $79.0M in cash against $150.6M in long-term debt as of Q3 2026.

Shares Outstanding
48M
YoY-3.2%
QoQ-1.9%
5Y CAGR-2.1%
10Y CAGR-1.5%

Crawford & Company had 48M shares outstanding in Q3 2026. This represents a decrease of 3.2% from the same quarter a year earlier. Against the prior quarter it is down 1.9%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
29.9%
YoY+1.7pp
QoQ+1.1pp
5Y change+3.9pp
10Y change+1.5pp

Crawford & Company's gross margin was 29.9% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Net Margin
4.5%
YoY+0.8pp
QoQ+0.5pp
5Y change+0.8pp
10Y change+0.8pp

Crawford & Company's net profit margin was 4.5% in Q3 2026, showing the share of revenue converted to profit. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Return on Equity
8.1%
YoY+1.5pp
QoQ+0.9pp
5Y change+3.0pp
10Y change+0.5pp

Crawford & Company's quarterly ROE was 8.1% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks
$13.5M
YoY+357.0%
QoQ+283.5%
5Y CAGR+34.4%
10Y CAGRn/m

Crawford & Company spent $13.5M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 357.0% from the same quarter a year earlier. Against the prior quarter it is up 283.5%.

Capital Expenditures
$857K
YoY-37.2%
QoQ-34.3%

Crawford & Company invested $857K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 37.2% from the same quarter a year earlier. Against the prior quarter it is down 34.3%.

R&D Spending

Not reported for Q3 2026.

CRD-A Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRD-A quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-K/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K/A
Revenue$329.9M-0.9%$330.0M-1.4%$320.1M-1.0%$320.1M-10.7%$332.8M-2.9%$334.6M+2.4%$323.3M+3.3%$358.3M+15.9%
Cost of Revenue$231.3M-3.2%$235.0M-0.5%$232.0M-0.5%$235.2M-10.7%$239.0M-4.1%$236.3M+0.6%$233.2M+3.3%$263.4M+14.5%
Gross Profit$98.6M+5.2%$95.0M-3.3%$88.1M-2.2%$84.9M-10.6%$93.8M+0.4%$98.3M+6.9%$90.1M+3.3%$94.9M+19.9%
SG&A Expenses$71.6M+3.2%$69.7M-11.1%$76.1M+2.1%$71.8M-8.5%$69.4M-3.0%$78.3M+8.4%$74.6M-3.5%$78.5M+4.9%
Interest Expense$2.9M-23.6%$2.9M-26.1%$2.6M-32.9%$3.1M-28.4%$3.8M-19.1%$3.9M-9.4%$3.9M+9.7%$4.3M+14.7%
Income Tax$7.3M+26.0%$6.2M+6.7%$2.4M-4.2%$786K-78.9%$5.8M+9.0%$5.8M+30.3%$2.5M+136.9%$3.7Mn/m
Net Income$15.0M+21.0%$13.4M+72.8%$4.9M-26.6%-$7.2M-226.5%$12.4M+31.3%$7.8M-9.3%$6.7M+135.6%$5.7Mn/m

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CRD-A Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRD-A quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-K/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K/A
Total Assets$769.1M-3.8%$758.3M-5.1%$771.6M-2.6%$764.3M-4.9%$799.8M-0.1%$799.4M+1.7%$792.3M+2.1%$803.8M+0.6%
Current Assets$380.4M+2.3%$362.8M-3.6%$368.3M-1.2%$352.4M-5.8%$371.7M+2.6%$376.2M+6.9%$372.8M+7.8%$374.2M+1.3%
Cash & Equivalents$79.0M+14.9%$69.4M+18.6%$54.5M-5.0%$64.1M+15.6%$68.8M+31.4%$58.5M+25.2%$57.4M+26.9%$55.4M-5.1%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Accounts Receivable$124.1M-3.4%$119.1M-12.5%$118.1M-12.0%$115.7M-18.6%$128.4M-2.2%$136.1M+1.7%$134.1M+6.5%$142.1M+8.1%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$76.4M-0.1%$76.4M-0.2%$76.5M+0.2%$76.6M+0.3%$76.5M-0.2%$76.6M0.0%$76.4M-0.3%$76.4M-0.5%
Total Liabilities$583.4M-4.8%$571.8M-8.1%$595.4M-5.7%$591.2M-8.6%$612.5M-4.3%$622.5M-1.9%$631.7M0.0%$646.5M-1.7%
Current Liabilities$323.9M+18.1%$305.4M+8.6%$323.2M+12.9%$309.6M+3.3%$274.3M-3.2%$281.1M+3.3%$286.2M+8.4%$299.7M+0.1%
Non-Current Liabilities$261.3M-23.1%$268.4M-21.7%$273.9M-21.1%$283.3M-18.7%$339.9M-5.1%$342.9M-5.8%$347.0M-5.9%$348.5M-3.2%
Long-Term Debt$150.6M-23.5%$150.6M-25.7%$150.6M-26.6%$150.6M-24.8%$196.8M-4.4%$202.7M-3.2%$205.3M-2.6%$200.3M+3.1%
Total Equity$185.7M-0.8%$186.4M+5.4%$176.3M+9.8%$173.1M+10.1%$187.3M+16.4%$176.9M+16.8%$160.6M+11.0%$157.2M+11.0%
Retained Earnings$235.3M-6.4%$236.6M-3.6%$230.0M-4.7%$233.7M-1.8%$251.5M+6.6%$245.5M+6.2%$241.2M+6.1%$237.9M+4.1%

Not reported in any period shown, so not listed: Inventory.

CRD-A Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRD-A quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-K/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K/A
Operating Cash Flow$5.8M-80.9%$19.9M-43.2%$3.3Mn/m$50.1M+23.7%$30.6M+58.3%$35.0M+203.1%-$13.9Mn/m$40.5M+13.5%
Depreciation & Amortization$9.4M-7.3%$9.5M-3.2%$9.6M-0.6%$10.5M+13.6%$10.1M+14.4%$9.8M+10.9%$9.6M+3.7%$9.2M+10.1%
Stock-Based CompensationN/AN/A$1.0M-24.7%N/AN/AN/A$1.4M+14.1%N/A
Capital Expenditures$857K-37.2%$1.3M-7.2%$1.9M+91.2%$3.2M+1.0%$1.4M-13.3%$1.4M$994K-35.5%$3.2M+110.3%
Free Cash Flow$5.0M-83.0%$18.6M-44.7%$1.4Mn/m$46.9M+25.7%$29.3M+64.7%$33.6M-$14.9Mn/m$37.3M+9.1%
Investing Cash Flow-$6.6Mn/m-$1.8Mn/m-$7.9Mn/m-$11.0Mn/m-$7.0Mn/m-$9.2Mn/m-$9.1Mn/m-$12.2Mn/m
Financing Cash Flow$8.5Mn/m-$8.0Mn/m$3.4M-86.4%-$43.8Mn/m-$12.7Mn/m-$26.1Mn/m$25.0M+55.6%-$26.2Mn/m
Dividends Paid$3.8M+2.3%$3.6M+5.4%$3.7M+6.0%$3.7M+7.4%$3.7M+8.2%$3.5M+0.7%$3.5M+0.3%$3.4M+0.5%
Share Buybacks$13.5M+357.0%$3.5Mn/m$5.5Mn/m$7.6M+2774.9%$3.0M+92.9%$0-100.0%$0-100.0%$263K-87.8%

CRD-A Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRD-A quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-K/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K/A
Gross Margin29.9%+1.7pp28.8%-0.6pp27.5%-0.4pp26.5%0.0pp28.2%+0.9pp29.4%+1.2pp27.9%0.0pp26.5%+0.9pp
Net Margin4.5%+0.8pp4.1%+1.7pp1.5%-0.5pp-2.3%-3.9pp3.7%+1.0pp2.3%-0.3pp2.1%+1.2pp1.6%+1.9pp
Return on Equity8.1%+1.5pp7.2%+2.8pp2.8%-1.4pp-4.2%-7.8pp6.6%+0.7pp4.4%-1.3pp4.2%+2.2pp3.6%+4.2pp
Return on Assets1.9%+0.4pp1.8%+0.8pp0.6%-0.2pp-0.9%-1.7pp1.6%+0.4pp1.0%-0.1pp0.8%+0.5pp0.7%+0.8pp
Current Ratio1.17-0.2x1.19-0.2x1.14-0.2x1.14-0.1x1.36+0.1x1.340.0x1.300.0x1.250.0x
Debt-to-Equity0.81-0.2x0.81-0.3x0.85-0.4x0.87-0.4x1.05-0.2x1.15-0.2x1.28-0.2x1.27-0.1x
Liabilities-to-Equity3.14-0.1x3.07-0.5x3.38-0.6x3.42-0.7x3.27-0.7x3.52-0.7x3.93-0.4x4.11-0.5x
Asset Turnover0.430.0x0.440.0x0.410.0x0.420.0x0.420.0x0.420.0x0.410.0x0.45+0.1x
FCF Margin1.5%-7.3pp5.6%-4.4pp0.4%+5.0pp14.6%+4.2pp8.8%+3.6pp10.0%-4.6%+2.2pp10.4%-0.7pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Crawford & Company CRD-A FY2025 $1.3B $19.6M 1.5% $553.3M 45/100
LendingTree, Inc. TREE FY2025 $1.1B $151.3M 13.5% $489.9M 47/100
AIFU Inc. AIFU FY2025 $79.6M -$325.4M N/A $437.4M 18/100
TWFG, Inc. TWFG FY2025 $248.5M $8.0M 3.2% $1.4B 85/100
Goosehead Insurance, Inc. GSHD FY2025 $365.3M $27.8M 7.6% $1.7B 65/100
XChange TEC.INC XHG FY2025 $51.3M -$105.1M N/A $171.7M 48/100

Frequently Asked Questions

Crawford & Company (CRD-A) reported $1.3B in total revenue for fiscal year 2025. This represents a -2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Crawford & Company (CRD-A) revenue declined by 2.2% year-over-year, from $1.3B to $1.3B in fiscal year 2025.

Yes, Crawford & Company (CRD-A) reported a net income of $26.1M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $19.6M, with a net profit margin of 1.5%.

As of fiscal year 2025, Crawford & Company (CRD-A) had $64.1M in cash and equivalents against $150.6M in long-term debt.

Crawford & Company (CRD-A) had a gross margin of 28.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Crawford & Company (CRD-A) had a net profit margin of 1.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Crawford & Company (CRD-A) has a return on equity of 11.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Crawford & Company (CRD-A) generated $94.8M in free cash flow during fiscal year 2025. This represents a 108.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Crawford & Company (CRD-A) generated $101.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Crawford & Company (CRD-A) had $764.3M in total assets as of fiscal year 2025, including both current and long-term assets.

Crawford & Company (CRD-A) invested $7.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Crawford & Company (CRD-A) spent $10.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Crawford & Company (CRD-A) had 49M shares outstanding as of fiscal year 2025.

Crawford & Company (CRD-A) had a current ratio of 1.14 as of fiscal year 2025, which is considered adequate.

Crawford & Company (CRD-A) had a debt-to-equity ratio of 0.87 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Crawford & Company (CRD-A) had a liabilities-to-equity ratio of 3.42 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Crawford & Company (CRD-A) had a return on assets of 2.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Crawford & Company (CRD-A) trades at 21.2x earnings, its market capitalization divided by $26.1M net income, trailing 12 months to September 30, 2026. The market capitalization is $553.3M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Crawford & Company (CRD-A) trades at 0.4x sales, its market capitalization divided by $1.3B revenue, trailing 12 months to September 30, 2026. The market capitalization is $553.3M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Crawford & Company (CRD-A) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Crawford & Company (CRD-A) has an earnings quality ratio of 5.19x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Crawford & Company (CRD-A) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top